Rationale for combined therapies in severe-to-critical COVID-19 patients
- Gonzaga, A.
- Andreu, E.
- Hernández-Blasco, L.M.
- Meseguer, R.
- Al-Akioui-Sanz, K.
- Soria-Juan, B.
- Sanjuan-Gimenez, J.C.
- Ferreras, C.
- Tejedo, J.R.
- Lopez-Lluch, G.
- Goterris, R.
- Maciá, L.
- Sempere-Ortells, J.M.
- Hmadcha, A.
- Borobia, A.
- Vicario, J.L.
- Bonora, A.
- Aguilar-Gallardo, C.
- Poveda, J.L.
- Arbona, C.
- Alenda, C.
- Tarín, F.
- Marco, F.M.
- Merino, E.
- Jaime, F.
- Ferreres, J.
- Figueira, J.C.
- Cañada-Illana, C.
- Querol, S.
- Guerreiro, M.
- Eguizabal, C.
- Martín-Quirós, A.
- Robles-Marhuenda, &Á.
- Pérez-Martínez, A.
- Solano, C.
- Soria, B.
- Show all authors +
Journal:
Frontiers in Immunology
ISSN: 1664-3224
Year of publication: 2023
Volume: 14
Type: Review